Section Arrow
CSCI.NASDAQ
- COSCIENS Biopharma Inc
Quotes are at least 15-min delayed:2025/06/02 03:48 EDT
Last
 3.37
-0.14 (-3.99%)
Day High 
3.51 
Prev. Close
3.51 
1-M High
3.8 
Volume 
825 
Bid
--
Ask
--
Day Low
3.37 
Open
3.51 
1-M Low
3.145 
Market Cap 
11.05M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 3.49 
20-SMA 3.53 
50-SMA 3.23 
52-W High 9.98 
52-W Low 1.96 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-6.33/-4.56
Enterprise Value
13.08M
Balance Sheet
Book Value Per Share
3.22
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
9.59M
Operating Revenue Per Share
2.85
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
INABIN8bio0.1446-0.0088-5.74%-- 
BLRXBioLineRx Ltd5.18+1.3891+36.64%-- 
IMNNImunon2.45+0.46+23.12%-- 
NCNANuCana plc0.03525-0.00175-4.73%-- 
MRNAModerna26.58-0.35-1.30%-- 
Quotes are at least 15-min delayed:2025/06/02 03:48 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.